These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14295795)

  • 21. [CYTOLOGICAL STUDY OF THE PROCESS OF IMMUNOGENESIS FOLLOWING ADMINISTRATION OF THE VI-ANTIGEN OF TYPHOID BACTERIA. I].
    POKROVSKAIA MP; KRASKINA NA; GUTOROVA NM; LEVENSON VI; ZHUKOV VG; ALLILUEV AP
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():9-14. PubMed ID: 14091809
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on experimental typhoid. 2. Nodule formation in the liver of the mouse immunized with dead vaccine of Escherichia coli].
    FUKAI K; OKONOGI T; MITSUHASHI S; KAWAKAMI M
    Nihon Saikingaku Zasshi; 1961 Nov; 16():933-6. PubMed ID: 13895783
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunological indices in subjects immunized with typhoid and paratyphoid B antigen IEM vaccine].
    SEMINA NA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Apr; 30(4):27-32. PubMed ID: 13660410
    [No Abstract]   [Full Text] [Related]  

  • 24. [Formation of immunity to typhoid following immunization with alcoholic typho-paratyphoid B divaccine].
    Pinegin BV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):23-6. PubMed ID: 6004904
    [No Abstract]   [Full Text] [Related]  

  • 25. [Live enteric typhoid vaccine consisting of a Vi-negative double-dependent mutant of S. typhi and a Vi-positive strain of Citrobacter].
    Pershin BB; Shuster BIu; Maganet LS; Tolcheev IuD
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):35-40. PubMed ID: 60853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
    Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
    Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [TYPHOID ANTIGENS AND TYPHOID IMMUNIZATION].
    JANDL G
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1964; 61():56-61. PubMed ID: 14336421
    [No Abstract]   [Full Text] [Related]  

  • 28. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 29. IMMUNIZATION AGAINST TYPHOID AND PARATYPHOID FEVERS.
    ASHCROFT MT
    Clin Pediatr (Phila); 1964 Jul; 3():385-93. PubMed ID: 14192459
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
    Lo NC; Gupta R; Stanaway JD; Garrett DO; Bogoch II; Luby SP; Andrews JR
    J Infect Dis; 2018 Nov; 218(suppl_4):S232-S242. PubMed ID: 29444257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [RESPONSE TO TYPHOID VACCINATION AFTER TREATMENT WITH ISONICOTINIC ACID HYDRAZIDE].
    GANDULLIA E; CORDONE G; FAMULARO L
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1461-4. PubMed ID: 14122291
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunization processes in experimental tetraethyl lead poisoning. IV. Behavior of typhoid antibodies during active immunization].
    BELLI R; GIULIANI V
    Folia Med (Napoli); 1955 Dec; 38(12):1407-12. PubMed ID: 13305654
    [No Abstract]   [Full Text] [Related]  

  • 33. Assay of typhoid vaccines in mice.
    Sterne M; Trim G
    J Med Microbiol; 1974 May; 7(2):197-203. PubMed ID: 4600291
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunization against typhoid fever.
    ASHCROFT MT
    West Indian Med J; 1963 Jun; 12():82-9. PubMed ID: 13965162
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunization in experimental tetraethyl lead poisoning. V. Presence of blocking antibodies in serum during active typhoid immunization].
    GIULIANI V; BELLI R
    Folia Med (Napoli); 1956 Feb; 39(2):147-53. PubMed ID: 13330924
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PREVENTIVE PROPERTIES OF SERA OF RABBITS IMMUNIZED WITH VACCINES PREPARED FROM LEVOMYCETIN-RESISTANT TYPHOID BACTERIA].
    GNETEV AM
    Antibiotiki; 1964 Jun; 9():524-8. PubMed ID: 14222465
    [No Abstract]   [Full Text] [Related]  

  • 38. [Properdin level and antibody production in the rabbit during immunization with Mycobacterium tuberculosis and Salmonella typhosa].
    HEYMANN G; WAHLIG H
    Z Immun exp ther; 1959 Jul; 118():57-72. PubMed ID: 14401639
    [No Abstract]   [Full Text] [Related]  

  • 39. [Laboratory research concerning the effectiveness of a typhoid-paratyphoid A and B vaccine administered orally].
    Nestoresco N; Vlădoianu IR; Dimache G; Dimache V; Petruşca J; Bórs A; Constantinesco L
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):417-22. PubMed ID: 4961444
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental basis for some of the problems of the enteral method of immunization. 3. Immunobiological properties of enteral typhoid-para-typhoid B vaccine].
    Mironova MV; Kovaleva NI; Khatuntseva NV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Mar; 50(3):83-9. PubMed ID: 4711426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.